Lansforsakringar Fondforvaltning Ab (Publ) Royalty Pharma PLC Transaction History
Lansforsakringar Fondforvaltning Ab (Publ)
- $17 Billion
- Q2 2025
A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 152,073 shares of RPRX stock, worth $5.75 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
152,073
Previous 150,558
1.01%
Holding current value
$5.75 Million
Previous $4.69 Million
16.92%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding RPRX
# of Institutions
509Shares Held
309MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.76 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.38 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$871 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$828 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$657 Million0.48% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.5B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...